Chloe P Whitworth

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Neoadjuvant Chemotherapy

Endothelial Cells

High Throughput

Tyrosine Kinase

Top Venues

Science advances

Expert opinion on drug discovery

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Wen Yih Aw, Aanya Sawhney, Mitesh L Rathod, Chloe P Whitworth, Elizabeth L Doherty, Ethan Madden, Jingming Lu, Kaden Westphal, Ryan Stack, William J Polacheck
Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations. bioRxiv : the preprint server for biology (2024)
Chloe P Whitworth, William J Polacheck
Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling. Expert opinion on drug discovery 19 (3) (2023)
Chloe P Whitworth, William J Polacheck
Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling. Expert opinion on drug discovery 19 (3) (2023)
Wen Yih Aw, Crescentia Cho, Hao Wang, Anne Hope Cooper, Elizabeth L Doherty, David J Rocco, Stephanie A Huang, Sarah Kubik, Chloe P Whitworth, Ryan Armstrong, Anthony J Hickey, Boyce E Griffith, Matthew L Kutys, Julie Blatt, William J Polacheck
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation. Science advances 9 (7) (2023)
Chloe P Whitworth, William J Polacheck
Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling. Expert opinion on drug discovery 19 (3) (2023)
Wen Yih Aw, Crescentia Cho, Hao Wang, Anne Hope Cooper, Elizabeth L Doherty, David J Rocco, Stephanie A Huang, Sarah Kubik, Chloe P Whitworth, Ryan Armstrong, Anthony J Hickey, Boyce E Griffith, Matthew L Kutys, Julie Blatt, William J Polacheck
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation. Science advances 9 (7) (2023)
Chloe P Whitworth, William J Polacheck
Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling. Expert opinion on drug discovery (2023)
Wen Yih Aw, Crescentia Cho, Hao Wang, Anne Hope Cooper, Elizabeth L Doherty, David J Rocco, Stephanie A Huang, Sarah Kubik, Chloe P Whitworth, Ryan Armstrong, Anthony J Hickey, Boyce E Griffith, Matthew L Kutys, Julie Blatt, William J Polacheck
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation. Science advances 9 (7) (2023)
Wen Yih Aw, Crescentia Cho, Hao Wang, Anne Hope Cooper, Elizabeth L Doherty, David J Rocco, Stephanie A Huang, Sarah Kubik, Chloe P Whitworth, Ryan Armstrong, Anthony J Hickey, Boyce E Griffith, Matthew L Kutys, Julie Blatt, William J Polacheck
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation. Science advances 9 (7) (2023)
Wen Yih Aw, Crescentia Cho, Hao Wang, Anne Hope Cooper, Elizabeth L Doherty, David J Rocco, Stephanie A Huang, Sarah Kubik, Chloe P Whitworth, Ryan Armstrong, Anthony J Hickey, Boyce E Griffith, Matthew L Kutys, Julie Blatt, William J Polacheck
Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation. Science advances 9 (7) (2023)